Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
September 11, 2025 17:01 ET | Source: Achieve Life Sciences SEATTLE and…
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
June 26, 2025 23:43 ET | Source: Achieve Life Sciences SEATTLE and…
